47 y/o Male Referred for Evaluation of Obesity, Type 2 Diabetes & Dyspnea on Exertion: Incorporating SGLT-2 Inhibitors in T2DM for Cardiorenal Protection

582 views
September 22, 2020
Comments 1
Login to view comments. Click here to Login